HomeInsightsStock Comparison

Dr Lalchandani Labs Ltd vs Narayana Hrudayalaya Ltd Stock Comparison

Dr Lalchandani Labs Ltd vs Narayana Hrudayalaya Ltd Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

  • The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.95 as of 29 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Narayana Hrudayalaya Ltd changed from 44.6 on March 2022 to 40.7 on March 2026 . This represents a CAGR of -1.81% over 5 years The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Narayana Hrudayalaya Ltd changed from ₹ 8299 crore on March 2021 to ₹ 32813 crore on March 2026 . This represents a CAGR of 25.75% over 6 years The revenue of Dr Lalchandani Labs Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Narayana Hrudayalaya Ltd for the Sep '26 is ₹ 2895 crore as compare to the Jun '26 revenue of ₹ 2719 crore. This represent the growth of 6.49% The ebitda of Dr Lalchandani Labs Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Narayana Hrudayalaya Ltd for the Sep '26 is ₹ 603.01 crore as compare to the Jun '26 ebitda of ₹ 503.27 crore. This represent the growth of 19.82% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Narayana Hrudayalaya Ltd changed from ₹ 201.49 crore to ₹ 301.15 crore over 10 quarters. This represents a CAGR of 17.44% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Narayana Hrudayalaya Ltd changed from 15.3 % on March 2022 to 18.28 % on March 2026 . This represents a CAGR of 3.62% over 5 years .

About Dr Lalchandani Labs Ltd

  • Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
  • Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
  • The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Narayana Hrudayalaya Ltd

  • Narayana Hrudayalaya Limited was incorporated on 19 July 2000 by Dr. Devi Prasad Shetty as its Founder.
  • The Company is primarily engaged in the business of rendering medical and healthcare services.
  • It has a network of multispeciality, and super speciality hospitals spread across multiple locations.
  • The Company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals. During the financial year ended 31 March 2016, Company acquired the entire remaining 26% in Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) from Infrastructure Development Corporation (Karnataka) Limited (IDECK) by paying Rs 3,025.60 Lacs as total purchase consideration to make NHSHPL as its wholly owned subsidiary.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Narayana Hrudayalaya Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Narayana Hrudayalaya Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Narayana Hrudayalaya Ltd is 35,143 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Narayana Hrudayalaya Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Narayana Hrudayalaya Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Narayana Hrudayalaya Ltd?

As of October 31, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.95. On the other hand, Narayana Hrudayalaya Ltd stock price is INR ₹1719.7.

How do dividend payouts of Dr Lalchandani Labs Ltd and Narayana Hrudayalaya Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Narayana Hrudayalaya Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions